SpringHill Management - aVenture Asset Manager Research
SpringHill Management
Operating Status: Operating
SpringHill: A private equity manager specializing in early-stage investments and development capital.
Location
Bramley, Surrey, GB
Founded
2001
SpringHill Management specializes in biotech and social venture capital investments, focusing on early-stage opportunities and development capital. The firm operates as a private equity fund manager, with a particular interest in impact investing across various global markets.
Chairman Dr. Kim Tan leads SpringHill and is involved in several impact funds, including Inqo Investments, Novastar Ventures, Springhill Equity Partners, and Garden Impact Investment. The firm's portfolio includes Dmed, which has raised $50 million. SpringHill's involvement in the Transformational Business Network and Dr. Tan's role as a trustee for the John Templeton Foundation highlight the firm's commitment to socially responsible investing.
SpringHill Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series C1 (100.0%)
Stage Mix
Series C 100%
Concentration shown as share of disclosed investments by stage.
